Compare Intuitive Surgical, Inc. (ISRG) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Oklo Inc — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Oklo Inc trades at $34.7 (market cap $6.43B). The key difference: Intuitive Surgical, Inc. is far larger — about 22.8× Oklo Inc's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Oklo Inc for 32 Days on average.
| ISRG | OKLO | |
|---|---|---|
Market Cap | $146.76B | $6.43B |
Volume | 2,529,814 | 16,238,368 |
Sector | Health | Utilities |
52-Week High | $592.85 | $174.14 |
52-Week Low | $332.02 | $34.57 |
Typical Hold Time | 84 Days | 32 Days |
Enterprise Value | $141.54B | $3.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
OKLO trades at $34.57, down 6.11% with bearish technical signals despite strong analyst support. The company shows no revenue in 2025 with significant losses (-$105.66M net income) and negative margins, though cash flow from financing provides runway. Recent news highlights nuclear sector volatility and OKLO's $1 billion stock sale raising dilution concerns.
Outlook hinges on project execution amid high risk-reward dynamics. Analyst consensus is bullish (71% Buy) with a $78.63 price target, but profitability challenges and cash burn pose substantial risks. Success depends on commercializing its nuclear reactor pipeline to capitalize on the growing AI power demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
